Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Carbidopa-Levodopa 25-250 (carbidopa-levodopa) Treatment Report
What is Carbidopa-Levodopa 25-250?

Levodopa 250 mg, a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease is combined with carbidopa 25 mg. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Muscle spasms 1 0

Mouse over the table for more information

Dosages

  3 x 25 mg-250 mg daily
  1 Number of Patients: 1  

Currently Taking Carbidopa-Levodopa 25-250

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.